Both Pete and Jenn bring strong leadership and unique perspectives, as well as impressive track records of innovation and management to our team,” said Prize4Life CEO, Avi Kremer.
Cambridge, MA (PRWEB) December 21, 2012
Prize4Life, a nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease), is pleased to announce the appointment of Mr. Peter Frates and Ms. Jennifer Mayo to the organization’s Board of Directors.
Mr. Frates is a 2007 graduate of Boston College where he double majored in Communications and History, earning a B.S. in both fields. He was a member of the Boston College Men’s Baseball team and served as captain during his senior year. Upon graduation, Mr. Frates played professional baseball for the Hamburg Stealers based in Hamburg, Germany. He then returned to the United States where he worked at organizations including EMC2, Sun Life Financial, and Humana. In March of 2012, Mr. Frates was diagnosed with ALS. Following his diagnosis, he has become a tireless crusader in the fight against ALS, raising thousands of dollars for research and increasing awareness about the need for treatments and a cure for the disease. Mr. Frates lives in Beverly, Massachusetts with his family and fiancée, Julie Kowalik.
Ms. Mayo is Pete’s sister. She is a 2004 graduate of Boston College where she attended the Wallace E. Carroll School of Management, earning a B.S. in Accounting and Finance. Ms. Mayo graduated with honors and soon thereafter began a career at The Goldman Sachs Group in both its London, UK and New York, NY offices. Her most recent role at Goldman Sachs was as a Vice President in the Infrastructure Investment Group. Following her brother’s ALS diagnosis, Ms. Mayo moved back to the Boston area where she now works to support Pete in the fight against ALS. She lives in Beverly, Massachusetts with her husband and daughter.
“Both Pete and Jenn bring strong leadership and unique perspectives, as well as impressive track records of innovation and management to our team,” said Prize4Life CEO, Avi Kremer. “Their individual and combined contributions to raising awareness about the need for new treatments and a cure for ALS will, undoubtedly, help us to achieve this goal as soon as possible.”
Prize4Life is a 501(c)(3) nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease) by using powerful incentives to attract new people and drive innovation. Prize4Life believes that solutions to some of the biggest challenges in ALS research will require out-of-the-box thinking, and that some of the most critical discoveries may come from unlikely places. Founded in 2006 by Avi Kremer, who was diagnosed with ALS at the age of 29, Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. For more information, visit http://www.prize4life.org.